Search
forResearch 10 of 1000+
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- Avaliação de respostas defensivas associadas ao pânico em ratas: perfil da ativação serotonérgica no núcleo dorsal da rafe e substância cinzenta periaquedutal
- ADVANCEMENTS IN TREATMENT STRATEGIES FOR ANDROGENETIC ALOPECIA: NOVEL THERAPIES AND FUTURE PERSPECTIVES
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- Dermatologic Side Effects of Psychotropic Medications
- Effect of ethanol Adiantum capillus-veneris extract in experimental models of anxiety and depression
- American College of Veterinary Behaviorists 2003 Scientific Session Abstracts
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania
Community 2 of 9
- GT20029 China Phase II Trial For AGA Reached Primary Endpoint
- PYRILUTAMIDE PHASE 3 RESULTS : No statistical significance
Learn
— no results
Try a deeper search in learn →